288 related articles for article (PubMed ID: 32697762)
1. The biological and diagnostic roles of MicroRNAs in meningiomas.
Wang L; Chen S; Liu Y; Zhang H; Ren N; Ma R; He Z
Rev Neurosci; 2020 Oct; 31(7):771-778. PubMed ID: 32697762
[TBL] [Abstract][Full Text] [Related]
2. Posttranscriptional deregulation of signaling pathways in meningioma subtypes by differential expression of miRNAs.
Ludwig N; Kim YJ; Mueller SC; Backes C; Werner TV; Galata V; Sartorius E; Bohle RM; Keller A; Meese E
Neuro Oncol; 2015 Sep; 17(9):1250-60. PubMed ID: 25681310
[TBL] [Abstract][Full Text] [Related]
3. Expression of miRNA-451 and miRNA-885 in Meningiomas.
Baran O; Karaoglu AC; Kara E; Budun O; Katar S; Yilmaz SG; Akdeniz FT; Ambarcioglu MA; Demirel N; Turk O; Ozdemir NG; Yaltirik CK; Isbir T
In Vivo; 2023; 37(6):2473-2479. PubMed ID: 37905647
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA Dysregulation in Canine Meningioma: RT-qPCR Analysis of Formalin-Fixed Paraffin-Embedded Samples.
Foiani G; Guelfi G; Mandara MT
J Neuropathol Exp Neurol; 2021 Sep; 80(8):769-775. PubMed ID: 34272938
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous analysis of miRNA-mRNA in human meningiomas by integrating transcriptome: A relationship between PTX3 and miR-29c.
Dalan AB; Gulluoglu S; Tuysuz EC; Kuskucu A; Yaltirik CK; Ozturk O; Ture U; Bayrak OF
BMC Cancer; 2017 Mar; 17(1):207. PubMed ID: 28327132
[TBL] [Abstract][Full Text] [Related]
6. MiR-34a-3p alters proliferation and apoptosis of meningioma cells
Werner TV; Hart M; Nickels R; Kim YJ; Menger MD; Bohle RM; Keller A; Ludwig N; Meese E
Aging (Albany NY); 2017 Mar; 9(3):932-954. PubMed ID: 28340489
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-195 Functions as a Tumor Suppressor by Directly Targeting Fatty Acid Synthase in Malignant Meningioma.
Song LR; Li D; Weng JC; Li CB; Wang L; Wu Z; Zhang JT
World Neurosurg; 2020 Apr; 136():e355-e364. PubMed ID: 31927122
[TBL] [Abstract][Full Text] [Related]
8. A microRNA expression signature predicts meningioma recurrence.
Zhi F; Zhou G; Wang S; Shi Y; Peng Y; Shao N; Guan W; Qu H; Zhang Y; Wang Q; Yang C; Wang R; Wu S; Xia X; Yang Y
Int J Cancer; 2013 Jan; 132(1):128-36. PubMed ID: 22674195
[TBL] [Abstract][Full Text] [Related]
9. Molecular biology of brain meningiomas.
Byvalsev VA; Stepanov IA; Belykh EG; Yarullina AI
Patol Fiziol Eksp Ter; 2017; 61(2):82-91. PubMed ID: 29215848
[TBL] [Abstract][Full Text] [Related]
10. Expression of miRNA-21, miRNA-107, miRNA-137 and miRNA-29b in meningioma.
Katar S; Baran O; Evran S; Cevik S; Akkaya E; Baran G; Antar V; Hanimoglu H; Kaynar MY
Clin Neurol Neurosurg; 2017 May; 156():66-70. PubMed ID: 28349893
[TBL] [Abstract][Full Text] [Related]
11. miRNA-145 is downregulated in atypical and anaplastic meningiomas and negatively regulates motility and proliferation of meningioma cells.
Kliese N; Gobrecht P; Pachow D; Andrae N; Wilisch-Neumann A; Kirches E; Riek-Burchardt M; Angenstein F; Reifenberger G; Riemenschneider MJ; Meese E; Panayotova-Dimitrova D; Gutmann DH; Mawrin C
Oncogene; 2013 Sep; 32(39):4712-20. PubMed ID: 23108408
[TBL] [Abstract][Full Text] [Related]
12. SNHG1/miR-556-5p/TCF12 feedback loop enhances the tumorigenesis of meningioma through Wnt signaling pathway.
Zhang Y; Yu R; Li Q; Li Y; Xuan T; Cao S; Zheng J
J Cell Biochem; 2020 Feb; 121(2):1880-1889. PubMed ID: 31692066
[TBL] [Abstract][Full Text] [Related]
13. The Expression of MIR17HG Protein as a Potential Therapeutic Target in Meningioma.
Evran S; Baran O; Kayhan A; Katar S; Akkaya E; Cevik S; Kaya M; Sonmez D; Serin H; Kaynar MY
World Neurosurg; 2020 May; 137():e554-e563. PubMed ID: 32068173
[TBL] [Abstract][Full Text] [Related]
14. Meningioma protein-protein interaction network.
Zali H; Rezaei Tavirani M
Arch Iran Med; 2014 Apr; 17(4):262-72. PubMed ID: 24724603
[TBL] [Abstract][Full Text] [Related]
15. MiRNA as potential biomarkers and therapeutic targets for gastric cancer.
Shin VY; Chu KM
World J Gastroenterol; 2014 Aug; 20(30):10432-9. PubMed ID: 25132759
[TBL] [Abstract][Full Text] [Related]
16. Multiplatform profiling of meningioma provides molecular insight and prioritization of drug targets for rational clinical trial design.
Everson RG; Hashimoto Y; Freeman JL; Hodges TR; Huse J; Zhou S; Xiu J; Spetzler D; Sanai N; Kim L; Kesari S; Brenner A; De Monte F; Heimberger A; Raza SM
J Neurooncol; 2018 Sep; 139(2):469-478. PubMed ID: 29846894
[TBL] [Abstract][Full Text] [Related]
17. Integrative genomic analysis identifies CCNB1 and CDC2 as candidate genes associated with meningioma recurrence.
Bie L; Zhao G; Ju Y; Zhang B
Cancer Genet; 2011 Oct; 204(10):536-40. PubMed ID: 22137483
[TBL] [Abstract][Full Text] [Related]
18. A serum 6-miRNA panel as a novel non-invasive biomarker for meningioma.
Zhi F; Shao N; Li B; Xue L; Deng D; Xu Y; Lan Q; Peng Y; Yang Y
Sci Rep; 2016 Aug; 6():32067. PubMed ID: 27558167
[TBL] [Abstract][Full Text] [Related]
19. miR-335 promotes cell proliferation by directly targeting Rb1 in meningiomas.
Shi L; Jiang D; Sun G; Wan Y; Zhang S; Zeng Y; Pan T; Wang Z
J Neurooncol; 2012 Nov; 110(2):155-62. PubMed ID: 22886530
[TBL] [Abstract][Full Text] [Related]
20. LncRNA-IMAT1 Promotes Invasion of Meningiomas by Suppressing KLF4/hsa-miR22-3p/Snai1 Pathway.
Ding Y; Ge Y; Wang D; Liu Q; Sun S; Hua L; Deng J; Luan S; Cheng H; Xie Q; Gong Y; Zhang T
Mol Cells; 2022 Jun; 45(6):388-402. PubMed ID: 35680373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
